# Sintx Technologies, Inc.: filings

SINT · Nasdaq · CIK 1269026 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sint.md) · [Financials](/companies/sint/financials.md) · [Filings](/companies/sint/filings.md) · [Insiders](/companies/sint/insiders.md)

## Reports and events: 323 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 203, 4 77, 10-Q 38, 424B3 34, S-1/A 30, CORRESP 29, 3 20, EFFECT 20, 424B5 18, UPLOAD 16, 10-K 13, DEF 14A 13, SC 13G/A 12, S-3 11, SC 13G 11, 10-Q/A 9, S-1 9, SCHEDULE 13G 8, 424B4 7, D 7, DEFA14A 7, PRE 14A 7, FWP 4, SCHEDULE 13G/A 4, 10-K/A 3, 8-K/A 3, D/A 3, NT 10-Q 3, S-1MEF 3, S-3/A 3, S-8 3, POS AM 2, 144 1, 8-A12B 1, CERTNAS 1, CT ORDER 1, DEFN14A 1, DEFR14A 1, DRS 1, NT 10-K 1, POS EX 1, PREC14A 1, SC 13D 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:05 ET | [DEF 14A](/filings/0001493152-26-049429.md) | Proxy statement, period 2026-10-30 | 0001493152-26-049429 |
| 2026-10-09 | 17:00 ET | [8-K](/filings/0001493152-26-046576.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-046576 |
| 2026-10-01 | 09:05 ET | [8-K](/filings/0001493152-26-045278.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-045278 |
| 2026-08-13 | 09:05 ET | [8-K](/filings/0001493152-26-037613.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-037613 |
| 2026-08-11 | 16:10 ET | [8-K](/filings/0001493152-26-037130.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037130 |
| 2026-08-11 | 16:05 ET | [10-Q](/filings/0001493152-26-037116.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037116 |
| 2026-07-23 | 09:05 ET | [8-K](/filings/0001493152-26-034343.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034343 |
| 2026-07-02 | 17:00 ET | [8-K](/filings/0001493152-26-031949.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-031949 |
| 2026-06-03 | 09:30 ET | [8-K](/filings/0001493152-26-026985.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-026985 |
| 2026-05-27 | 15:00 ET | [8-K](/filings/0001493152-26-025377.md) | 3.01 Delisting notice | 0001493152-26-025377 |
| 2026-05-15 | 17:01 ET | [10-Q](/filings/0001493152-26-023919.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023919 |
| 2026-03-20 | 17:00 ET | [10-K](/filings/0001493152-26-011924.md) | Annual report, period 2025-12-31 | 0001493152-26-011924 |
| 2026-02-18 | 08:35 ET | [8-K](/filings/0001493152-26-007271.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-007271 |
| 2025-12-01 | 08:35 ET | [8-K](/filings/0001493152-25-025496.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025496 |
| 2025-11-13 | 08:05 ET | [8-K](/filings/0001493152-25-022125.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-022125 |
| 2025-11-12 | 16:17 ET | [10-Q](/filings/0001493152-25-021930.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021930 |
| 2025-10-03 | 17:07 ET | [8-K](/filings/0001493152-25-016904.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-016904 |
| 2025-09-09 | 06:05 ET | [8-K](/filings/0001493152-25-012834.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-012834 |
| 2025-09-05 | 16:15 ET | [8-K](/filings/0001493152-25-012731.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-012731 |
| 2025-08-14 | 16:16 ET | [10-Q](/filings/0001641172-25-024040.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024040 |
| 2025-07-31 | 17:00 ET | [DEF 14A](/filings/0001641172-25-021774.md) | Proxy statement, period 2025-07-31 | 0001641172-25-021774 |
| 2025-07-22 | 07:15 ET | [8-K](/filings/0001641172-25-020513.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-020513 |
| 2025-06-27 | 16:15 ET | [8-K](/filings/0001641172-25-016891.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-016891 |
| 2025-05-22 | 07:15 ET | [8-K](/filings/0001641172-25-011981.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-011981 |
| 2025-05-15 | 07:10 ET | [8-K](/filings/0001641172-25-010503.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-010503 |
| 2025-05-15 | 07:00 ET | [10-Q](/filings/0001641172-25-010496.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010496 |
| 2025-05-07 | 17:00 ET | [8-K](/filings/0001641172-25-009063.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-009063 |
| 2025-04-08 | 16:30 ET | [8-K](/filings/0001641172-25-003233.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-003233 |
| 2025-03-19 | 08:00 ET | [10-K](/filings/0001493152-25-010870.md) | Annual report, period 2024-12-31 | 0001493152-25-010870 |
| 2025-03-13 | 16:15 ET | [8-K](/filings/0001493152-25-010204.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-010204 |
| 2025-02-26 | 08:30 ET | [8-K](/filings/0001493152-25-008277.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-008277 |
| 2025-02-20 | 06:10 ET | [8-K](/filings/0001493152-25-007635.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-007635 |
| 2024-12-23 | 16:15 ET | [8-K](/filings/0001493152-24-051827.md) | 5.07 Shareholder vote results | 0001493152-24-051827 |
| 2024-12-13 | 16:15 ET | [8-K](/filings/0001493152-24-049998.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-049998 |
| 2024-11-29 | 13:15 ET | [8-K](/filings/0001493152-24-048140.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-048140 |
| 2024-11-19 | 17:13 ET | [8-K](/filings/0001493152-24-046863.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-046863 |
| 2024-11-18 | 06:15 ET | [8-K](/filings/0001493152-24-046415.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-046415 |
| 2024-11-14 | 16:15 ET | [DEF 14A](/filings/0001493152-24-045881.md) | Proxy statement, period 2024-11-14 | 0001493152-24-045881 |
| 2024-11-12 | 15:50 ET | [10-Q](/filings/0001493152-24-044728.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044728 |
| 2024-11-01 | 16:30 ET | [8-K](/filings/0001493152-24-043336.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-043336 |
| 2024-09-26 | 16:30 ET | [8-K](/filings/0001493152-24-038318.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-038318 |
| 2024-08-13 | 16:32 ET | [10-Q](/filings/0001493152-24-031644.md) | Quarterly report, period 2024-06-30 | 0001493152-24-031644 |
| 2024-08-06 | 09:05 ET | [8-K](/filings/0001493152-24-030376.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-030376 |
| 2024-07-11 | 16:45 ET | [8-K](/filings/0001493152-24-026966.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-026966 |
| 2024-06-12 | 09:05 ET | [8-K](/filings/0001493152-24-023552.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-023552 |
| 2024-05-23 | 09:10 ET | [8-K](/filings/0001493152-24-021101.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-021101 |
| 2024-05-15 | 09:00 ET | [8-K](/filings/0001493152-24-019556.md) | 5.07 Shareholder vote results | 0001493152-24-019556 |
| 2024-05-13 | 17:20 ET | [10-Q](/filings/0001493152-24-018961.md) | Quarterly report, period 2024-03-31 | 0001493152-24-018961 |
| 2024-04-30 | 09:00 ET | [8-K](/filings/0001493152-24-017156.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-017156 |
| 2024-04-12 | 16:01 ET | [8-K](/filings/0001493152-24-014441.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-24-014441 |

Page 1 of 7. [Older](/companies/sint/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:10 ET. No prices; not investment advice.